egfrcancer.org
New Data Challenge Current Standard in Treating EGFR+ Lung Cancer
*September 2019* by Dr. Mark Kris for Medscape This is Mark Kris from Memorial Sloan Kettering. Just when we thought we were all set with EGFR, suddenly we have some disruptive information that challenges how we're going to treat patients with EGFR-mutated cancers. At the American Society of Clinical Oncology (ASCO) annual meeting this year,